CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 26 enrolled
Drug / intervention
Flunisolide HFAdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02404103
NCT02404103N/ACompleted
CompareCT.gov

Flunisolide HFA in Children With Small Airway Disease

University of Louisville·interventional·Posted Mar 31, 2015·Updated Dec 14, 2017

In Brief

A clinical study evaluating Flunisolide HFA for Childhood Asthma. Completed, enrolled 26 participants across 1 site.

Detailed Summary

The purpose of this study is to see how two doses of Flunisolide HFA (an FDA approved inhaled medication to treat asthma) affect the small airways in children with asthma.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChildhood Asthma
CountriesUnited States
CollaboratorsMeda Pharmaceuticals

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedMar 31, 2015
Enrollment StartMar 1, 2015
Primary CompletionMay 1, 2017
Study CompletionJun 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 11.3 years ago

Interventions

Flunisolide HFAdrug